Notable insider buying and selling activity across public companies.
Tracking and analysis of reported insider transactions, including executive and director buying or selling. Insider activity can offer insight into internal confidence, valuation perceptions, and potential inflection points.
5,053 total articles
Keysight Technologies Executive Vice President and Chief Financial Officer Neil Dougherty sold 2,000 shares of the company’s common stock on March 24, 2026, for $298.37 per share, a transaction valued at $596,740. The sale takes place after an 87% rise in Keysight shares over the prior 12 months, at a time when InvestingPro analysis indicates the s…
Jeffrey K. Li, senior vice president and secretary of Keysight Technologies (NASDAQ: KEYS), sold 2,000 shares of company stock on March 24, 2026, in a transaction valued at $594,380. The sale was reported on a Form 4 filing with the Securities and Exchange Commission and leaves Li with direct ownership of 34,499.146 shares. The transaction took pla…
Lee Kang Jyh, a member of Photronics Inc.'s board, sold 10,000 shares on March 23, 2026, in a transaction valued at $390,000, according to a new Form 4 filing. The filing also revises prior reported beneficial ownership totals. The move comes amid a strong share-price run and after the company posted fiscal Q1 2026 results that topped estimates, wh…
Ana G. Pinczuk, SentinelOne’s President of Product & Technology, sold 32,396 Class A shares on March 25, 2026, for $433,134 as the company mandated the sale to meet tax withholding tied to performance-based restricted stock units. The company also disclosed senior leadership appointments and expanded partnerships with Google Cloud and LevelBlue.
Barry L. Padgett, interim chief financial officer of SentinelOne, sold 32,221 Class A shares on March 25, 2026, at $13.37 per share for roughly $430,794 to satisfy tax-withholding requirements. Two days earlier he was credited with 92,662 Class A shares at a $0 value following certification of the first tranche of a performance-based restricted sto…
SentinelOne President and CEO Tomer Weingarten disposed of 72,523 shares of Class A common stock on March 25, 2026, in a transaction mandated to satisfy tax withholding related to the vesting and settlement of performance-based restricted stock units. The sale totaled $969,632 at $13.37 per share. The company has recently completed related share is…
Keenan Michael Conder, SentinelOne's Chief Legal Officer and Secretary, sold 5,578 Class A shares on March 25, 2026 to satisfy tax withholding tied to the vesting and settlement of performance-based restricted stock units. Two days earlier Conder received separate performance-based RSU awards that resulted in the acquisition of 9,074 and 13,715 sha…
SentinelOne Chief Accounting Officer Robin Tomasello sold 1,496 shares of Class A common stock on March 25, 2026, for $13.37 per share, generating $20,001. The transaction follows an earlier certification-based issuance of restricted stock units and leaves Tomasello with just over 403,000 direct shares. Separately, SentinelOne announced senior lead…
Glaukos Corporation's Senior Vice President and Chief Financial Officer Alex R. Thurman sold 1,521 shares on March 24 at $105.24 for $160,070, and separately sold additional shares on March 23 and March 24 to satisfy tax withholding obligations. The tax-related sales - 1,230 shares on March 23 and 2,020 shares on March 24 - occurred at prices betwe…
Andrew Kang, Executive Vice President and Chief Financial Officer of Strategy Inc (NASDAQ: MSTR), sold 3,373 shares of Class A common stock on March 24, 2026, in multiple transactions to meet tax obligations tied to the vesting of equity awards. The disposals generated about $328,265. Kang had exercised restricted stock units the previous day to ac…
Le Phong, President and CEO of Strategy Inc (NASDAQ:MSTR), sold 3,309 shares of Class A common stock on March 24, 2026 for roughly $456,362 under a Rule 10b5-1 plan to satisfy tax obligations tied to vested equity awards. The transactions coincided with a separate RSU exercise and follow the company's large Bitcoin acquisitions funded through equit…
Jeanine Montgomery, Vice President and Chief Accounting Officer of Strategy Inc (NASDAQ:MSTR), sold 470 shares of Class A Common Stock on March 24, 2026, for roughly $65,016 to satisfy tax obligations related to vested equity. The transaction, disclosed on a Form 4 filing, occurred as the company continued to add to its Bitcoin holdings and as anal…
Talphera Inc. CEO Vincent J. Angotti acquired 213,310 shares at $0.586 per share on March 13, 2026, for a total of $124,999 as part of a previously announced PIPE. The purchase leaves Angotti with 800,705 directly held shares, including 10,000 from the company’s Employee Stock Purchase Plan. The transaction price was roughly 27% below the current m…
Multiple TCG Crossover entities purchased common stock of Surrozen, Inc. (NASDAQ: SRZN) on March 23 and March 24, 2026, for a combined transaction value of $3,012,767 at prices between $24.6931 and $24.8999. The trades occurred as the stock traded around $26.14, after substantial gains over the past year and six months. Analysts retain optimistic p…
Chaya Eri, a director at RH, sold 7,000 shares on March 24, 2026 for a total of $905,950 and exercised options to acquire 7,000 shares at $39.42. The transactions leave her with no direct common shares but an indirect holding through a trust and substantial option exposure. The company is navigating analyst price-target cuts, varied ratings, and se…
TeraWulf INC. (NASDAQ:WULF) Chief Executive Officer Paul B. Prager sold $4,544,999 worth of company shares across several transactions at prices between $16.0969 and $17.617 per share. The sales occurred on March 24 and March 25, 2026, as the stock trades close to its 52-week high of $18.51. Following the disposals, Prager retains direct ownership …
Cryoport Inc. (NASDAQ: CYRX) Chief Scientific Officer Mark W. Sawicki sold 1,341 shares of the company's common stock on March 23, 2026 for $8.18 per share, a transaction totaling $10,969. The sale was carried out to satisfy tax obligations tied to the vesting of restricted stock rights, according to the company's policies. After the disposition, S…
Cryoport Inc.'s Chief Financial Officer Robert Stefanovich sold 1,094 shares on March 23, 2026, at $8.18 per share for $8,948 to meet tax liabilities tied to vested restricted stock. After the sale Stefanovich owns 279,277 shares. The stock trades at $8.41 with a market capitalization of $417.79 million. Separately, Cryoport reported Q4 2025 revenu…
Cryoport President and CEO Jerrell Shelton sold 2,894 shares on March 23, 2026, and exercised options to acquire 25,000 shares the same day. The company reported fourth-quarter 2025 revenue above consensus but an earnings per share shortfall; InvestingPro flags the stock as appearing overvalued at current levels.
CoreWeave Chief Development Officer Brannin McBee sold Class A Common Stock on March 23, 2026, through a pre-arranged 10b5-1 trading plan, realizing roughly $11.8 million across multiple transactions. The filings show detailed tranches of shares sold by McBee, by his spouse and by his irrevocable trust at prices between $81.0558 and $84.7348. On th…
CoreWeave Chief Development Officer Brannin McBee, acting indirectly, sold 17,015 shares of Class A common stock on March 23, 2026 under a Rule 10b5-1 trading plan for roughly $1.89 million in proceeds and also converted 22,915 Class B shares into Class A on the same day. The transaction was executed through Canis Major 2025 GRAT and Canis Minor 20…
Comstock Holding Companies Chief Operating Officer Timothy Steffan sold 9,740 Class A shares on March 23, 2026 for roughly $152,028 and concurrently exercised options to purchase 15,000 shares at $3.30 each. After the transactions Steffan directly holds 115,767 shares. The insider move comes as CHCI shares have risen 64% over the past year, trading…
Reddit Chief Technology Officer Christopher Brian Slowe sold 9,400 shares of Class A Common Stock on March 23, 2026, for roughly $1.34 million via multiple trades under a Rule 10b5-1 plan. The same day he exercised options to acquire 7,500 shares at $7.92 each and moved 2,000 shares into a family trust. The insider activity accompanies robust fourt…
Protagonist Therapeutics President and CEO Dinesh V. Patel sold 54,700 shares at $101 each on March 24 and 25, 2026, for a total of $5,524,700. Filings show he also exercised options for 54,700 shares at $8.58 per share on the same dates and gifted 50,000 shares on March 23, 2026. The transactions coincide with Protagonist's recent FDA approval of …
NextNav Chief Operating Officer Susan Brasse Insley sold 2,370 shares of common stock on March 24, 2026, in a transaction totaling $44,015 under a Rule 10b5-1 plan. The sale occurred while the stock traded close to its 52-week high and follows the company’s Q4 2025 results showing a net loss but a strong liquidity position and progress in PNT techn…
